Free Trial
Cory Kasimov

Cory Kasimov Analyst Performance

Senior Managing Director Equities at Evercore ISI

Cory Kasimov is a stock analyst at Evercore ISI focused in the medical sector, covering 47 publicly traded companies. Over the past year, Cory Kasimov has issued 10 stock ratings, including buy and hold recommendations. While full access to Cory Kasimov's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Cory Kasimov's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
439 Last 11 Years
Buy Recommendations
65.06% 283 Buy Ratings
Companies Covered
47 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy65.1%283 ratings
Hold31.7%138 ratings
Sell3.2%14 ratings

Out of 435 total stock ratings issued by Cory Kasimov at Evercore ISI, the majority (65.1%) have been Buy recommendations, followed by 31.7% Hold and 3.2% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
93.6% of companies on NASDAQ
44 companies
NYSE
6.4% of companies on NYSE
3 companies

Cory Kasimov, an analyst at Evercore ISI, currently covers 47 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
41 companies
87.2%
Miscellaneous
5 companies
10.6%
Finance
1 company
2.1%

Cory Kasimov of Evercore ISI specializes in stock coverage within the Medical sector, with additional focus on and Finance companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
25 companies
53.2%
PHARMACEUTICAL PREPARATIONS
6 companies
12.8%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC
5 companies
10.6%
Miscellaneous
5 companies
10.6%
MED - DRUGS
3 companies
6.4%
FIN - INVEST BKRS
1 company
2.1%
BIOTECHNOLOGY
1 company
2.1%
LARGE CAP PHARMA
1 company
2.1%

About Cory Kasimov

Cory Kasimov Senior Managing Director EquitiesNew York Cory Kasimov is a senior managing director and fundamental research analyst at Evercore ISI, leading coverage of mid- and small-cap biotech companies. Mr. Kasimov’s two decades of research experience includes over 15 years as a senior biotech analyst at J.P. Morgan. His differentiated, actionable research product and educational events have led to consistent recognition in the Institutional Investor (now Extel) All-America Research survey, where he has placed in the top 3 in the large-cap biotech sector and as high as No. 2 in the SMID biotech category. Mr. Kasimov earned an MBA in finance and marketing from Tulane University’s A.B. Freeman School of Business and an MPH in health systems management from Tulane’s School of Public Health and Tropical Medicine. He also holds a B.S. in cellular and molecular biology from Tulane.
Follow on LinkedIn

Cory Kasimov's Ratings History at Evercore ISI

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
9/3/2025Initiated Coverage$5.00$12.00Outperform
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
9/3/2025Boost Price Target$49.60$80.00Outperform
Immunome, Inc. stock logo
IMNM
Immunome
8/22/2025Initiated Coverage$10.40$18.00Outperform
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
8/12/2025Boost Price Target$28.25$34.00Outperform
Moderna, Inc. stock logo
MRNA
Moderna
8/1/2025Set Price Target$29.56$32.00
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
5/14/2025Initiated Coverage$29.31$55.00Outperform
Moderna, Inc. stock logo
MRNA
Moderna
5/2/2025Lower Price Target$27.33$32.00In-Line
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
4/24/2025Lower Price Target$101.83$185.00Outperform
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
3/12/2025Initiated Coverage$18.50$30.00Outperform
Moderna, Inc. stock logo
MRNA
Moderna
1/27/2025Lower Price Target$43.01$50.00In-Line